ESPs containing Ultromics
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
Computer-aided diagnostic imaging utilizes algorithms to detect, extract, and communicate data from medical images more efficiently and accurately than the human eye. The technology is being deployed across several imaging modalities to improve the detection, diagnosis, triaging, and, ultimately, the prognosis of various medical conditions.
Ultromics's Products & Differentiation
See Ultromics's products and how their products differentiate from alternatives and competitors
Ultromics’ products operate through the cloud, as a Software-as-a-Service (SaaS) connected with Microsoft Azure cloud. Once connected, starting scanning, and let Ultromics take care of analysis. We’ll provides reports without the need to for any physical software or manual interaction, with results trusted globally by sites including Mayo Clinic, Cleveland Clinic, and the American Society of Echocardiography.
When was Ultromics founded?
Ultromics was founded in 2017.
Where is Ultromics's headquarters?
Ultromics's headquarters is located at 4630 Kingsgate, Oxford.
What is Ultromics's latest funding round?
Ultromics's latest funding round is Series B.
How much did Ultromics raise?
Ultromics raised a total of $57.7M.
Who are the investors of Ultromics?
Investors of Ultromics include Oxford Sciences Innovation, The Blue Venture Fund, Optum Ventures, Google Ventures, Nina Capital and 11 more.
Who are Ultromics's competitors?
Competitors of Ultromics include Aidoc Medical, Us2.ai, Viz.ai, Cleerly, Aidence, SenseTime, Overjet, Iterative Scopes, Aiforia, Lunit and 40 more.
What products does Ultromics offer?
Ultromics's products include EchoGo.
You May Also Like
Aidoc finds and flags critical findings in medical images. By automatically prioritizing urgent, life-threatening conditions like intracranial hemorrhage and pulmonary embolism, Aidoc saves lives, improves patient care and cuts waiting time for the must urgent patients down to only a few minutes. The always-on AI integrates into a radiologist's workflow, reprioritizing cases without forcing radiologists to change the way they work. Aidoc was founded in 2016 and is based in Tel Aviv, Israel.
Infervision is a global high-tech enterprise in medical artificial intelligence, aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome, and lower cost. Infervision provides products and services to providers, and patients; with robust A.I. solutions fully integrated with the healthcare workflow to help diagnosing various diseases and conditions such as cerebral hemorrhage, lung cancer, bone fractures, emphysema, and more. Infervision also provides an AI-powered research platform for medical professionals with any research directions and needs.
Koios Medical is a provider of software solutions for radiologists diagnosing cancer. Using AI algorithms trained on thousands of images combined with data from pathology results, Koios DS™ is decision support for healthcare diagnostics.
Quibim, a company with its headquarters in Valencia, Spain, provides a whole-body medical imaging analysis. Quibim products are used worldwide by a huge diversity of research and care teams. Partners use Quibim Precision, a CE-marked whole-body imaging ecosystem, for a wide range of applications from detecting a disease to tracking the efficacy of treatments. Quibim follows an AI-first approach to help detect pathologies across every body part and imaging modality, using quantitative imaging biomarkers.
Viz.ai aims to use artificial intelligence and deep learning to automatically identify suspected LVOs (large vessel occlusion) on CTA imaging with the aim of alerting a patient's physician within minutes. The company was founded in 2016 and is based in San Francisco, California.
Lunit is a medical AI software company devoted to providing AI solutions for cancer diagnostics and therapeutics. With its deep learning technology, Lunit makes data-driven medicine the new standard of care. Lunit AI solutions help discover cancer and predict cancer treatment response by finding the right diagnosis at the right costs and the right treatment for the right patients.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.